Ładuje się......
Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn’s disease
Since the approval of the first anti-tumor necrosis factor (anti-TNF) therapy in late 1998, the treatment for Crohn’s disease (CD) has been revolutionized. Anti-TNF therapy has been consistently shown in numerous clinical trials to be effective for patients with more aggressive perianal, internal pe...
Zapisane w:
| Wydane w: | Ther Adv Chronic Dis |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publications
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4416970/ https://ncbi.nlm.nih.gov/pubmed/25954499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315579621 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|